Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT

INTRODUCTION: Ventilator-associated pneumonia (VAP) is the most common healthcare-associated infection in critically ill patients. Prior studies suggest that probiotics may reduce VAP and other infections in critically ill patients; however, most previous randomised trials were small, single centre...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnstone, Jennie, Heels-Ansdell, Diane, Thabane, Lehana, Meade, Maureen, Marshall, John, Lauzier, Francois, Duan, Erick Huaileigh, Zytaruk, Nicole, Lamarche, Daphnee, Surette, Michael, Cook, Deborah J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596980/
https://www.ncbi.nlm.nih.gov/pubmed/31227528
http://dx.doi.org/10.1136/bmjopen-2018-025228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596980/
https://www.ncbi.nlm.nih.gov/pubmed/31227528
http://dx.doi.org/10.1136/bmjopen-2018-025228

Ejemplares similares